secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeloc Technologies, Inc (LCTC)
CIK:        0001493137
Form:       8-K
Filed at:   2022-05-12T23:59:59+00:00
Accession:  0001079973-22-000579
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifeloc Q1 2022 net loss $145K vs profit $403K in Q1 2021, revenue up 19% to $2.161M
--------------------------------------------------------------------------------

- Net loss of $145K ($0.06 diluted EPS) vs. net profit of $403K ($0.16 diluted EPS) in Q1 2021, which included a $465K PPP loan forgiveness gain.
- Revenue $2.161M, up 19% YoY, driven by demand recovery and new product adoption.
- R&D investment increased to develop SpinDx drug testing platform; expects initial SpinDx sales this year.
- New LX9 and LT7 devices driving strong sales growth; L-series products gaining market traction.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1493137/000107997322000579/0001079973-22-000579-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1493137/000107997322000579/lclc_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-22-000579

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer